Pfizer has announced third-quarter net profits of $866m (€618m), representing a 70pc drop from the same time last year.
Pfizer has announced that third-quarter 2010 revenues amounted to $16.2bn – an increase of 39pc compared with $11.6bn in the year-ago quarter.
Pfizer reported net income of $866m (€618m), a decrease of 70pc compared with $2.9bn in the prior-year quarter.
The company’s revenues for third-quarter 2010 were favourably impacted, compared with the same time last year, by $5.2bn, or 44pc.
The addition of the legacy Wyeth products were attributed to the drop from last year’s profits and negatively impacted the company to the tune of $458m, or 4pc.
US revenues remained high at $7.1bn – an increase of 48pc compared with a year ago, while international revenues performed better – $9.1bn, or an increase of 33pc compared to this time last year.
